增强现实喘吸入器的共同设计 儿童教育干预:发展和可用性研究
Antonia O'Connor1,2, Andrew Tai1,2,3, Malcolm Brinn4,5
1Respiratory and Sleep Department, Women's and Children's Hospital, Adelaide, Australia.
JMIR pediatrics and parenting
|July 25, 2023
概括
这项研究为患有喘的儿童开发了一个增强现实 (AR) 应用程序,以改善吸入器技术. 该应用程序与用户共同设计,显示出出色的可用性,并将为临床评估进行改进.
科学领域:
- 数字健康数字健康
- 儿科喘管理 儿科喘管理
- 人与计算机的交互
背景情况:
- 喘是最常见的慢性儿科疾病,在症状控制和吸入器坚持方面存在重大挑战.
- 现有的儿童喘教育应用程序很少,尽管孩子们在使用高科技.
- 增强现实 (AR) 为通过移动设备增强健康教育提供提供提供了一种新的方法.
研究的目的:
- 共同设计和开发一个使用AR的智能手机/平板电脑应用程序,用于儿科喘吸入器技术教育.
- 评估AR喘吸入器教育应用程序的可用性,使用系统可用性量表.
- 为儿童喘护理未来的数字健康干预提供建议.
主要方法:
- 一个代的共同设计过程,涉及患有喘的儿童,照顾者和医疗保健专业人员.
- 在整个开发周期中进行了定性采访和可用性测试.
- 该应用程序根据用户反进行了改进,包括动画和增强AR功能.
主要成果:
- 共同设计过程成功地将最终用户的偏好集成到AR喘吸入器应用程序中.
- 用户反导致了代改进,包括添加动画和删除AR的纸质触发器.
- 该应用程序实现了卓越的感知可用性,在最终评估中平均系统可用性量表得分高达90.14.
结论:
- 共同设计和可用性评估为强大的AR喘吸入器教育干预提供了基础.
- 开发的应用程序显示了通过引人入胜的技术改善儿科喘管理的巨大潜力.
- 计划进行进一步的临床评估,以评估该干预措施在现实环境中的有效性.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Inhaled Medications
313
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
313
Asthma: Pathogenesis and Management
447
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
447
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


